Stratview Research has published a new report titled “Methadone Market” which is segmented by Route Of Administration (Oral [Tablets, Oral solutions], Injectable), By Therapeutic Area (Pain treatment, Detoxification, Maintenance therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Rehab centers, Drug Stores), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).
As per the study, the market is estimated to grow at a healthy CAGR during the forecast period of 2021-2026.
Pain is one of the most widely recognized ailments and about 85% of individuals are accounted to suffer from pain worldwide at some point in their life. Methadone is a synthetic narcotic analgesic, which is a part of a category known as opioids. This opioid drug has pharmacologic actions qualitatively similar to that of morphine. It is mainly used as a pain reliever and as a part of maintenance therapy and drug addiction detoxification.
Report Highlights
This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the industry’s market dynamics. It provides a thorough analysis of the market segments which include products, applications, and competitor analysis.
The market is bifurcated into various segments. Below given is the segment-wise analysis -
Route of Administration Trends
By route of administration, the global methadone market has been bifurcated into oral and injectable.
- The oral segment is further segmented into tablets and oral solutions.
- Under these, the oral segment witnessed the largest market share in 2020 and is likely to register a moderate CAGR in the coming years.
- This is mainly attributed to the high-performance efficiency and easy availability of the drug in various forms and dosages.
Which Region is expected to remain the largest market?
By region, the North American market garnered the largest market share in 2020 and is likely to register a healthy CAGR during the review period.
- This is mainly attributed to the higher predominance of the agony and rising incidents of drug addiction, further boosting the regional growth.
- Moreover, high distress with rising occurrences of people utilization of methadone for chronic post-surgery pains.
Who are the Key Players in the Market?
This report provides market intelligence most comprehensively. It also provides critical insights into the key players active in the market, which will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players active in the Methadone Market:
- Eli Lilly and Company (The U.S)
- Sanofi (France)
- Roxane Laboratories (The U.S)
- Mallinckrodt (UK)
- Siegfried AG (Switzerland)
- Johnson Matthey (UK)
- Tianjin Central Pharma (China)
- Macfarlan Smith (UK)
- Vistapharm (The U.S)
Key questions answered by the report.
- What is the projected CAGR for revenue from the Methadone Market during the forecast period?
- What would the market be valued at by 2026?
- What is a major driving factor for the growth of the market?
- Which region accounted for the largest revenue share in the Methadone Market?
- Which are the major market players?
Custom Research:
Stratview Research delivers custom research services across sectors. In case of any custom research requirements, please send your inquiry to sales@stratviewresearch.com. Or connect with our experts at +1-313-307-4176.
About Us
Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients insightful market data to aid strategic decision-making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.
Write a comment